Comparison of the automated AxSYM and ADVIA Centaur immunoassays for homocysteine determination

Clinical Laboratory

Volumn 50, Issue 3-4, 2004, Pages 175-180

  Haltmayer, Meinhard ^a   Mueller, Thomas ^a   Gegenhuber, Alfons ^a   Poelz, Werner ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b JOHANNES KEPLER UNIVERSITY LINZ   (Austria)

Author keywords

Diagnosis; Homocysteine; Methods; Vascular diseases

Indexed keywords

HOMOCYSTEINE;

ACCURACY; AMINO ACID ANALYSIS; ANALYZER; ARTICLE; AUTOMATION; CALIBRATION; CASE CONTROL STUDY; CHEMOLUMINESCENCE; CLASSIFICATION; CLINICAL LABORATORY; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEVICE; DILUTION; ENZYME IMMUNOASSAY; FLUORESCENCE POLARIZATION IMMUNOASSAY; REGRESSION ANALYSIS; RELIABILITY; SAMPLE; STATISTICAL MODEL; VASCULAR DISEASE;

AUTOANALYSIS; CHEMILUMINESCENT MEASUREMENTS; CORONARY ARTERIOSCLEROSIS; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HOMOCYSTEINE; HUMANS; IMMUNOASSAY; MALE; REPRODUCIBILITY OF RESULTS;

EID: 1842817744     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Rasmussen K, Moller J. Total homocysteine measurement in clinical practice. Ann Clin Biochem 2000;37:627-48.
2. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem 1995:41:991-4.
3. Frantzen F, Faaren AL, Alfheim I, Nordhei AK. Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem 1998;44:311-6.
4. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995;274:1049-57.
5. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
6. Pernet P, Lasnier F, Vaubourdolle M. Evaluation of the AxSYM homocysteine assay and comparison with the IMx homocysteine assay. Clin Chem 2000;46:1440-1.
7. Mindicino HJ, Carlsen J, Tewari P, Aagaard O, Zhang B, Conarpe C. An evaluation of an automated homocysteine method on the Bayer ADVIA Centaur automated chemiluminescent system. Clin Lab 2002;48:493-6.
8. Zappacosta B, Persichilli S, Scribano D, et al. Comparing different methods for homocysteine determination. Clin Chem Lab Med 2002;40:1139-42.
9. National Committee for Clinical Laboratory Standards. Evaluation of the linearity of quantitative measurement procedures: a statistical approach; approved guideline. NCCLS document EP6-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 2003.
10. National Committee for Clinical Laboratory Standards. Evaluation of precision performance of clinical chemistry devices; approved guideline. NCCLS document EP5-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 1999.
11. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Comparison of the Biomedica NT-proBNP enzyme immunoassay and the Roche NT-proBNP chemiluminescence immunoassay: implications for the prediction of symptomatic and asymptomatic structural heart disease. Clin Chem 2003;49:976-9.
12. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem 1983;21:709-20.
13. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999;8:135-60.
14. Savage DG, Lindenbaum J, Stabler SP, Allen RH. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994;96:239-46.
15. Nexo E, Hansen M, Rasmussen K, Lindgren A, Grasbeck R. How to diagnose cobalamin deficiency. Scand J Clin Lab Invest Suppl 1994;219:61-76.
16. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1999;99:178-82.
17. Ubbink JB, Becker PJ, Vermaak WJ, Delport R. Results of B-vitamin supplementation study used in a prediction model to define a reference range for plasma homocysteine. Clin Chem 1995;41:1033-7.
18. Rasmussen K, Moller J, Lyngbak M, Pedersen AM, Dybkjaer L. Age- and gender-specific reference intervals for total homocysteine and methylmalonic acid in plasma before and after vitamin supplementation. Clin Chem 1996;42:630-6.
19. Jacobsen DW. Homocysteine and vitamins in cardiovascular disease. Clin Chem 1998;44:1833-43.
20. Rossi E, Beilby JP, McQuillan BM, Hung J. Biological variability and reference intervals for total plasma homocysteine. Ann Clin Biochem 1999;36:56-61.
21. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340:1449-54.